key: cord-0882444-6r6zwfoy authors: Wu, Huailiang; Huang, Jian; Zhang, Casper JP; He, Zonglin; Ming, Wai-kit title: Facemask shortage and the coronavirus disease (COVID-19) outbreak: Reflection on public health measures date: 2020-02-12 journal: nan DOI: 10.1101/2020.02.11.20020735 sha: 2cfe7a4cc1fceed0ad7ffbd6244a61e0b2c3ac8b doc_id: 882444 cord_uid: 6r6zwfoy To the best of our knowledge, this is the first study to investigate the facemask shortage during the novel coronavirus pneumonia (COVID-19) outbreak in China. We have summarized in detail the management strategies implemented by the Chinese governments during the outbreaks. By considering three scenarios for the outbreak development, we simulated the facemasks availability from late-December 2019 to late-April 2020 and estimated the duration of sufficient facemask supplies. Our findings showed that if the COVID-19 outbreak occurred only in Wuhan city or Hubei province, facemask shortage would not appear with the existing public health measures. However, if the outbreak occurred in the whole of China, a shortage of facemask could be substantial assuming no alternative public health measures. Supplies of facemasks in the whole of China would have been sufficient for both healthcare workers and the general population if the COVID-19 outbreak only occurred in Wuhan city or Hubei province. However, if the outbreak occurred in the whole of China, facemask supplies in China could last for 5 days if under the existing public health measures and a shortage of 853 million facemasks is expected by 30 Apr 2020. Assuming a gradually decreased import volume, we estimated that dramatic increase in productivity (42.7 times of the usual level) is needed to mitigate the facemask crisis by the end of April. In light of the COVID-19 outbreak in China, a shortage of facemasks and other medical resources can considerably compromise the efficacy of public health measures. Effective public health measures should also consider the adequacy and affordability of medical resources. Global collaboration should be strengthened to prevent the development of a global pandemic from a regional epidemic via easing the medical resources crisis in the affected countries. A novel coronavirus disease (COVID-19) outbreak due to SARS-CoV-2 infection occurred in China in late-December 2019. Facemask wearing is considered as one of the most cost-effective and important measures to prevent the transmission of SARS-CoV-2, but it became a social concern due to the recent global facemask shortage. China is the major facemask producer in the world, contributing to 50% of global production. However, even full productivity (20 million facemasks per day) does not seem to meet the need of a population of 1·4 billion in China. Policy review using government websites and shortage analysis using mathematical modelling based days if under the existing public health measures and a shortage of 853 million facemasks is expected by 30 Apr 2020. Assuming a gradually decreased import volume, we estimated that dramatic increase in productivity (42.7 times of the usual level) is needed to mitigate the facemask crisis by the end of April. In light of the COVID-19 outbreak in China, a shortage of facemasks and other medical resources can considerably compromise the efficacy of public health measures. Effective public health measures should also consider the adequacy and affordability of medical resources. Global collaboration should be strengthened to prevent the development of a global pandemic from a regional epidemic via easing the medical resources crisis in the affected countries. An increasing number of novel coronavirus disease cases were initially identified in Wuhan, Hubei province, China in December 2019. The novel coronavirus (SARS-CoV-2) was mainly transmitted via respiratory droplets and can be transmitted between humans 1-3 . Common symptoms of COVID-19 include fever, cough, dyspnoea, and myalgia or fatigue, while less common symptoms include sputum production, headache, haemoptysis, and diarrhoea 4 . In mid-February 2020, the reported incidence of COVID-19 cases exceeded 60,000 in China, of which more than 70% was in Wuhan city and more than 80% was in Hubei province 5,6 . Globally, Thailand, Japan, South Korea, Singapore, Malaysia, France, Canada, Australia, Germany, the United Kingdom, the United States and 13 other countries had reported COVID-19 cases 7 . Most of the confirmed cases are travellers from or ever been to Wuhan or other Chinese cities; however, locally transmitted cases outside of China have also been reported 7 . The World Health Organization's (WHO) guidance on prevention and control of the COVID-19 outbreak recommends hand, and respiratory hygiene and the use of appropriate personal protective equipment for healthcare workers in practice and patients with suspected SARS-CoV-2 infection should be offered a medical mask 8 . Regarding the respiratory hygiene measures, facemask wearing is considered as one of the most cost-effective and important measures to prevent the transmission of SARS-CoV-2, but it became a social concern due to the recent global facemask shortage 9-12 . China is the major facemask producer in the world, contributing to 50% of the global production 9 . At the usual time, China can produce 20 million facemasks per day while the productivity during the Chinese New Year holiday was lower (12 million facemasks per day) 13 . However, even full productivity does not seem to meet the need of a population of 1·4 billion in China. Therefore, to control the COVID-19 epidemic, the Chinese government imported more than 730 million facemasks between 24 Jan 2020 and 11 Feb 2020 13,14 and extended the Chinese New Year holiday to allow for home quarantine and to reduce the need for facemasks and other medical resources. A number of factories also resumed partial productivity during the holiday by paying extra to their workers 15 . In this study, we simulated the facemask availability during the COVID-19 outbreak using a mathematical model based on the actual development of the outbreak, public health measures introduced by the Chinese government, and national statistics on facemask production and import. We aim to investigate the situation of the facemask shortage during the COVID-19 outbreak in China and reflect on the existing public health measures. This analysis could provide insight into the development of emergency plans regarding the adequacy and affordability of medical resources for future infectious disease outbreaks. . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . https: //doi.org/10.1101 //doi.org/10. /2020 A cluster of COVID-19 cases was reported by the Wuhan Municipal Health Commission in late Dec 2019 1, and the peak of the epidemic is predicted to be between mid-to-late-February based on data from Wuhan while the epidemic is predicted to fade out within two months after the peak 16, 17 . The number of new cases is expected to decline after the epidemic peak, but the viral transmission is still possible and the need for facemask will not decrease immediately. Therefore, our analysis covered the period from 31 Dec 2019 to 30 Apr 2020 (121 days in total). To simulate the facemask availability in China, we used a mathematical model based on data and assumptions on the production, import, and need. We considered three scenarios in which the COVID-19 outbreak occurred in 1) Wuhan city (the epicenter); 2) Hubei province (the province/state where the epicenter is located); and 3) the whole of China (the entire country). We simulated the daily facemasks availability using equation (1), We estimated the daily need for facemasks using equations (2) to (4), where F n,h (d) and F n,g (d) are the need for facemasks among healthcare workers and the general population on day d in the disease epidemic region, respectively. author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10. 1101 /2020 Disease Control and Prevention (CDC) of the People's Republic of China, and Municipal Health Commission. The parameters included in the mathematical model were estimated based on the data released by the NHC, MIIT, and CDC of the People's Republic of China or recent investigation on the outbreak. Model input and assumptions in our model are summarized in Table 1 . Specifically, the population and the numbers of healthcare workers in Wuhan city, Hubei province, and China were obtained from the Wuhan Bureau of Statistics and China Health Statistics Yearbook 2019 [18] [19] [20] . MIIT estimated that the daily facemask production in China is about 20 million at usual time 13 . Facemask storage was estimated to be seven times the daily consumption in hospitals 9 . We assume that 70% of the facemask storage in the whole of China would be supplied to the hospital system; thus, the baseline facemasks availability (F a (0)) was estimated to be 246,006,500, which is about 12 times of the usual daily facemask productivity in China. In our model, we assumed all facemasks on the market and in storage are available for consumption. In other words, we did not take into account factors that may limit the supply on the market, such as logistics. We assumed that the daily facemask productivity (F p (d)) changed during our prediction period due to the Chinese New Year holiday (24 Jan 2020 to 9 Feb 2020), the incentive to resume production, and new product lines. Specifically, we considered three scenarios for the changes of daily facemask productivity, i.e., 1) 100% productivity (20 million per day) before the Chinese New Year holiday, 40% to 60% productivity during the holiday, and 94% to 100% productivity after the holiday; 2) 100% productivity before the Chinese New Year holiday, 40% to 60% productivity during the holiday, and the productivity would increase from 94% after the holiday to 200% on 3 Mar 2020; 3) 100% productivity before the Chinese New Year holiday, 40% to 60% productivity during the holiday, and the productivity would increase from 94% to 400% on 3 Mar 2020 (See Table 1 for detailed description of each scenario). According to the MIIT and General Administration of Customs, the daily number of facemasks imported to China were 6,000,000 between 24 Jan 2020 and 29 Jan 2020, 20,000,000 on 30 Jan 2020 13 , 56,166,667 between 31 Jan 2020 and 11 Feb 2020 14 . Given a global facemask shortage has appeared in mid-February, we assumed a gradually decreasing daily import of facemask between 12 Feb 2020 and 23 Mar 2020 from 50% to 10% of the import volume in early-February and maintained a 10% of the import volume in early-February from 23 Mar 2020 to 30 Apr 2020. Based on the clinical experience of chief physicians in China, we assumed that each healthcare worker would use five facemasks each day (α) at the usual time. And we assumed that each person in the general population would use one facemask each day (β). We assumed the percentage of the general population wearing facemasks (P g (d) ) to be close to 0% before the release of the national technical protocol for SARS-CoV-2 (the first version) by the NHC (i.e., 0